SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$81.85
-1.36% today
Updated 2026-10-28
Market cap
$14.54B
P/E ratio
10.45
P/S ratio
1.75x
EPS (TTM)
$8.17
Dividend yield
—
52W range
$62 – $94
Volume
1.0M
Solventum Corp. (SOLV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$81.85
12-Month target
$64.67
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $8.1B | $8.2B | $8.3B | $8.3B | $8.6B | $8.8B | $9.0B | $9.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 2.72% (capped 20%) · P/E: 10.45x (capped 25x) · Margin: 17.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.